Cargando…

Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies

Determination of poliovirus-neutralizing antibodies is an important part of clinical studies of poliovirus vaccines, epidemiological surveillance and seroprevalence studies that are crucial for global polio eradication campaigns. The conventional neutralization test is based on inhibition of cytopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manukyan, Hasmik, Petrovskaya, Svetlana, Chumakov, Konstantin, Laassri, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157629/ https://www.ncbi.nlm.nih.gov/pubmed/32150852 http://dx.doi.org/10.3390/vaccines8010120

Ejemplares similares

Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine
por: Manukyan, Hasmik, et al.
Publicado: (2019)

Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine
por: Manukyan, Hasmik, et al.
Publicado: (2022)

Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2
por: Manukyan, Hasmik, et al.
Publicado: (2021)

Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples
por: Manukyan, Hasmik, et al.
Publicado: (2023)

Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications
por: Korotkova, Ekaterina, et al.
Publicado: (2017)

Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
por: Puligedda, Rama Devudu, et al.
Publicado: (2020)

Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture
por: Plant, Ewan P., et al.
Publicado: (2020)

Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine
por: Konz, John O., et al.
Publicado: (2021)

A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2016)

Epidemiology of Type 3 Poliovirus AFP Cases in Israel between 1973 and 1988: Whole Genome Sequencing of RNA Extracted Directly from Archived Stocks to Avoid Re-Culturing Neurovirulent Wild Poliovirus
por: Shulman, Lester M., et al.
Publicado: (2022)

A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes
por: Charnesky, Andrew J., et al.
Publicado: (2023)

Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
por: Opare, Joseph KL, et al.
Publicado: (2019)

Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine
por: Giri, Sidhartha, et al.
Publicado: (2018)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses
por: Majid, Laassri, et al.
Publicado: (2015)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

Immune Pressure on Polymorphous Influenza B Populations Results in Diverse Hemagglutinin Escape Mutants and Lineage Switching
por: Plant, Ewan P., et al.
Publicado: (2020)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies
por: Cook, Nathan, et al.
Publicado: (2021)

Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method
por: Evans, Mark C, et al.
Publicado: (2014)

Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
por: Miyaji, Karina Takesaki, et al.
Publicado: (2017)

High neutralizing antibody titer in intensive care unit patients with COVID-19
por: Liu, Li, et al.
Publicado: (2020)

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines
por: Kung, Yu-An, et al.
Publicado: (2023)

Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays
por: Blevins, Tamara P., et al.
Publicado: (2019)

Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody
por: Moscato, Giovanna, et al.
Publicado: (2021)

Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
por: Connelly, Guinevere G., et al.
Publicado: (2022)

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system
por: Luo, Xiaoyi, et al.
Publicado: (2023)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Innate cell markers that predict anti-HIV neutralizing antibody titers in vaccinated macaques
por: Van Tilbeurgh, Matthieu, et al.
Publicado: (2022)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

A neutralization assay for chikungunya virus infections in a multiplex format
por: Weber, Christopher, et al.
Publicado: (2014)

Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay
por: Danh, Kenneth, et al.
Publicado: (2020)

In-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers
por: Ma, Hong-Wei, et al.
Publicado: (2017)

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fok81ejh8nn9r7jet7oqqrhf7b